PINK
NLBS

Nutralife Biosciences Inc

Drug Manufacturers-Specialty & Generic
Healthcare

Prices are adjusted according to historical splits.

Nutralife Biosciences Inc Stock Price

Vitals

Today's Low:
$0.0003
Today's High:
$0.0003
Open Price:
$0.0003
52W Low:
$0.0003
52W High:
$0.078
Prev. Close:
$0.0003
Volume:
0

Company Statistics

Market Cap.:
$52986
Book Value:
-0.013
Revenue TTM:
$631957
Operating Margin TTM:
-380.48%
Gross Profit TTM:
$83588
Profit Margin:
0%
Return on Assets TTM:
-28.48%
Return on Equity TTM:
-1426.02%

Company Profile

Nutralife Biosciences Inc had its IPO on under the ticker symbol NLBS.

The company operates in the Healthcare sector and Drug Manufacturers-Specialty & Generic industry. Nutralife Biosciences Inc has a staff strength of 12 employees.

Stock update

Shares of Nutralife Biosciences Inc opened at $0 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $0 - $0, and closed at $0.

This is a 0% increase from the previous day's closing price.

A total volume of 0 shares were traded at the close of the day’s session.

In the last one week, shares of Nutralife Biosciences Inc have increased by 0%.

Nutralife Biosciences Inc's Key Ratios

Nutralife Biosciences Inc has a market cap of $52986, indicating a price to book ratio of 85.5064 and a price to sales ratio of 14.0861.

In the last 12-months Nutralife Biosciences Inc’s revenue was $631957 with a gross profit of $83588 and an EBITDA of $-2175289. The EBITDA ratio measures Nutralife Biosciences Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Nutralife Biosciences Inc’s operating margin was -380.48% while its return on assets stood at -28.48% with a return of equity of -1426.02%.

In Q3, Nutralife Biosciences Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 63%.

Nutralife Biosciences Inc’s PE and PEG Ratio

Forward PE
0
Trailing PE
0
PEG

Its diluted EPS in the last 12-months stands at $-0.02 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Nutralife Biosciences Inc’s profitability.

Nutralife Biosciences Inc stock is trading at a EV to sales ratio of 18.366 and a EV to EBITDA ratio of -6.7856. Its price to sales ratio in the trailing 12-months stood at 14.0861.

Nutralife Biosciences Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$6.03 million
Total Liabilities
$4.45 million
Operating Cash Flow
$-503200.00
Capital Expenditure
$503200
Dividend Payout Ratio
0%

Nutralife Biosciences Inc ended 2024 with $6.03 million in total assets and $0 in total liabilities. Its intangible assets were valued at $6.03 million while shareholder equity stood at $-2315288.00.

Nutralife Biosciences Inc ended 2024 with $0 in deferred long-term liabilities, $4.45 million in other current liabilities, 17656.00 in common stock, $-50720940.00 in retained earnings and $0 in goodwill. Its cash balance stood at $431713.00 and cash and short-term investments were $431713.00. The company’s total short-term debt was $2,766,927 while long-term debt stood at $10000.00.

Nutralife Biosciences Inc’s total current assets stands at $873552.00 while long-term investments were $1.28 million and short-term investments were $0. Its net receivables were $48717.00 compared to accounts payable of $192268.00 and inventory worth $373204.00.

In 2024, Nutralife Biosciences Inc's operating cash flow was $-503200.00 while its capital expenditure stood at $503200.

Comparatively, Nutralife Biosciences Inc paid $0 in dividends in 2024.

Other key metrics

Current Trading Price
$0
52-Week High
$0.078
52-Week Low
$0.0003
Analyst Target Price
$

Nutralife Biosciences Inc stock is currently trading at $0 per share. It touched a 52-week high of $0.078 and a 52-week low of $0.078. Analysts tracking the stock have a 12-month average target price of $.

Its 50-day moving average was $0.01 and 200-day moving average was $0.03 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 4594.7% of the company’s stock are held by insiders while 0% are held by institutions.

Frequently Asked Questions About Nutralife Biosciences Inc

The stock symbol (also called stock or share ticker) of Nutralife Biosciences Inc is NLBS

The IPO of Nutralife Biosciences Inc took place on

Similar Industry Stocks (Drug Manufacturers-Specialty & Generic)

Last Price
Chg
Chg%
$19.62
0.01
+0.05%
$2.06
-0.04
-1.9%
$0.01
-0
-5.68%
$187.3
-3.8
-1.99%
$9
0.1
+1.12%
$4.16
0.3
+7.77%
$0.03
-0
-11.57%
$302.7
-13.85
-4.38%
$27.56
-0.4
-1.43%

Most Active

Last Price
Chg
Chg%
Amyris Inc (AMRS)
$0.14
0.07
+100%
$0.12
0.04
+45.29%
$0.96
0.05
+5.4%
$1.34
-0.35
-20.71%
Humbl Inc (HMBL)
$0
0
0%

Top Gainers

Last Price
Chg
Chg%
$0
0
+172200%
$0
0
+51200%
$283
280.03
+9428.62%
$11.2
10.57
+1667.68%
Latch Inc (LTCHW)
$0.01
-0.03
+1550%

Top Losers

Last Price
Chg
Chg%
$0.19
-123.15
-99.85%
$0
-0.11
-99.55%
$0
-0
-97.96%
$0
-0.01
-93.94%
$0.01
-0.06
-92.24%

About

NutraLife BioSciences, Inc., together with its subsidiaries, engages in the development, manufacture, and distribution of nutraceutical, dietary, wellness, and cannabidiol (CBD) products. Its CBD products include cannabinoid-rich hemp oil derived from industrial hemp; tinctures; topical lotions and oils applied directly to the skin to treat pain or inflammation; face creams; massage oils; nutraceutical sprays with CBD as an added ingredient; and pet products. The company also offers other products, such as skincare and sanitizer products. NutraLife BioSciences, Inc. sells its products through nutralifebiosciences.com, as well as through private label distributors, online retailers, and retail outlets. The company was formerly known as NutraFuels, Inc. and changed its name to NutraLife BioSciences, Inc. in March 2019. NutraLife BioSciences, Inc. was incorporated in 2010 and is based in Coconut Creek, Florida.

Address

6601 Lyons Road, Coconut Creek, FL, United States, 33073